Several lines of evidence have suggested that BCL6 and BACH2 cooperate in GC B-cells [49,50,51], thus understanding the clinical significance of such transcriptional regulators in CLL patients and the protein networks influenced by them is of high importance in CLL treatment. The gene discussed is BCL6; the disease is B-cell chronic lymphocytic leukemia.